v3.20.2

STOCK WARRANTS AND STOCK OPTIONS (Tables)

9 Months Ended

Sep. 30, 2020

STOCK WARRANTS AND STOCK OPTIONS

Schedule of fair value of non-employee stock/warrants

		Sept. 30, 2020				Sept. 30, 2019
Exercise Price		$	0.50			$ 0.06 - 0.2
Dividend Yield			0	%			0	%
Volatility			153	%		134% - 138		%
Risk-free Interest Rate			0.29	%		1.83% – 2.53		%
Life of Warrants		5 Years				5 Years

Schedule of outstanding warrants

		Warrants Outstanding Number of Shares				Exercise Price Per Share				Weighted Average Remaining Contractual Life		Weighted Average Exercise Price Per Share				Aggregate Intrinsic Value
Balance at December 31, 2018			721,678			$0.1397 - 0.6319				3.45 Years		$	0.1929			$	-
Warrants Granted			772,261			$0.06 - 0.2062				4.50 Years		$	0.1231			$	161,129
Warrants Exercised			(1,038,339	)		$0.06 - 0.5322						$	0.1630
Warrants Expired			(1,503	)		$	0.6319					$	0.6319
Balance at September 30, 2019			454,097			$.1330 - 0.1530				4.55 Years		$	0.1463			$	85,158

		Warrants Outstanding Number of Shares				Exercise Price Per Share				Weighted Average Remaining Contractual Life		Weighted Average Exercise Price Per Share				Aggregate Intrinsic Value
Balance at December 31, 2019			598,414			$	0.13304 – 1.039375			3.97 Years		$	0.3607			$	1,276,870
Warrants Granted			320,000			$	0.50			4.68 Years		$	0.50			$	761,600
Warrants Exercised			(454,097	)		$	0.13304 - 0.15299					$	0.1451
Warrants Expired			-
Balance at September 30, 2020			464,317			$0.50 - 1.039375				3.91 Years		$	0.66765			$	1,027,234

Exercisable at December 31, 2019			598,414				$0.13304 – 1.039375			3.97 Years		$	0.3607			$	1,276,870
Exercisable at September 30, 2020			464,317				$0.50 - 1.039375			3.91 Years		$	0.66765			$	1,027,234

Schedule of fair value of stock option granted

		September 30, 2020				September 30, 2019
Exercise Price		$0.26-3.30					-
Dividend Yield			0	%			-
Expected Volatility		153%-171		%			-
Risk Free Interest Rate		0.19%-0.43		%			-
Expected Life		2.2-5 years					-

Schedule of outstanding options

		Options Outstanding Number of Shares				Exercise Price Per Share				Weighted Average Remaining Contractual Life		Weighted Average Exercise Price Per Share				Aggregate Intrinsic Value
Balance at December 31, 2018			53,367			$0.1497 – 8.31				2.32 Years		$	0.2761			$	-
Options Granted			-				-
Options Exercised			-				-
Options Cancelled			(45,100	)		$	0.1497					$	0.1497
Options Expired			-				-
Balance at September 30, 2019			8,267			$0.2328 – 8.31				0.07 Years		$	0.9678			$	-

		Options Outstanding Number of Shares				Exercise Price Per Share				Weighted Average Remaining Contractual Life		Weighted Average Exercise Price Per Share				Aggregate Intrinsic Value
Balance at December 31, 2019			2,381,239			$0.2634 - 1.039				8.86 Years		$	0.2946			$	5,238,080
Options Granted			160,000			$0.2634 – 3.30				4.10 Years		$	1.9454			$	149,532
Options Exercised			-				-
Options Cancelled			-				-
Options Expired			-				-
Balance at September 30, 2020			2,541,239			$0.26342 – 3.30				7.86 Years		$	0.3987			$	6,305,579

Exercisable at December 31, 2019			539,847				$0.2634 – 1.03938			8.93 Years		$	0.4			$	1,129,786
Exercisable at September 30, 2020			1,213,060				$0.26342 – 3.30			8.21 Years		$	0.5009			$	2,885,963

X

- References

No definition available.

+ Details

Name:	imle_ScheduleOfFairValueOfStockOptionGrantedtabletextblock
Namespace Prefix:	imle_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_WarrantsAndRightsNoteDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration